T
Tempie E. Hulbert-Shearon
Researcher at University of Michigan
Publications - 28
Citations - 8203
Tempie E. Hulbert-Shearon is an academic researcher from University of Michigan. The author has contributed to research in topics: Hemodialysis & Dialysis. The author has an hindex of 23, co-authored 28 publications receiving 7847 citations. Previous affiliations of Tempie E. Hulbert-Shearon include University of Colorado Denver & University of Cologne.
Papers
More filters
Journal ArticleDOI
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
TL;DR: This study concludes that a large percentage of hemodialysis patients who have a serum phosphorus level above 6.5 mg/dL and that this places them at increased risk of death, and supports the need for vigorous control of hyperphosphatemia to improve patient survival.
Journal ArticleDOI
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.
Santhi K. Ganesh,Austin G. Stack,Nathan W. Levin,Tempie E. Hulbert-Shearon,Friedrich K. Port +4 more
TL;DR: This study identifies strong relationships between elevated serum PO(4), Ca xPO(4) product, and parathyroid hormone and cardiac causes of death in HD patients, especially deaths resulting from CAD and sudden death.
Journal ArticleDOI
Type of vascular access and mortality in U.S. hemodialysis patients
TL;DR: This case-mix adjusted analysis suggests that CVC and AVG are correlated with increased mortality risk when compared with AVF, both overall and by major causes of death.
Journal ArticleDOI
Deceased-donor characteristics and the survival benefit of kidney transplantation.
Robert M. Merion,Valarie B. Ashby,Robert A. Wolfe,Dale A. Distant,Tempie E. Hulbert-Shearon,Robert A. Metzger,Akinlolu O. Ojo,Friedrich K. Port +7 more
TL;DR: ECD kidney transplants should be offered principally to candidates older than 40 years in OPOs with long waiting times, and candidates should be counseled that ECD survival benefit is observed only for patients with diabetes.
Journal ArticleDOI
Predictors of Loss of Residual Renal Function among New Dialysis Patients
Louise Moist,Friedrich K. Port,Sean M. Orzol,Eric W. Young,Truls Østbye,Robert A. Wolfe,Tempie E. Hulbert-Shearon,Camille A. Jones,Wendy E. Bloembergen +8 more
TL;DR: Predictors of RRF loss were female gender, non-white race, prior history of diabetes, and time to follow-up, and use of a calcium channel blocker, all of which were independently associated with decreased risk ofRRF loss.